Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications.
Ontology highlight
ABSTRACT: Immune microenvironment and immunotherapy have become the focus and frontier of tumor research, and the immune checkpoint inhibitors has provided novel strategies for tumor treatment. Malignant pleural effusion (MPE) is a common end-stage manifestation of lung cancer, malignant pleural mesothelioma and other thoracic malignancies, which is invasive and often accompanied by poor prognosis, affecting the quality of life of affected patients. Currently, clinical therapy for MPE is limited to pleural puncture, pleural fixation, catheter drainage, and other palliative therapies. Immunization is a new direction for rehabilitation and treatment of MPE. The effusion caused by cancer cells establishes its own immune microenvironment during its formation. Immune cells, cytokines, signal pathways of
SUBMITTER: Ge S
PROVIDER: S-EPMC10936107 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA